Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin k in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial☆

[1]  J. Douketis,et al.  Treatment of warfarin-associated coagulopathy: a physician survey. , 2001, Chest.

[2]  J. Douketis,et al.  Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial , 2000, The Lancet.

[3]  D. Witt,et al.  Randomized, Placebo‐Controlled Trial of Oral Phytonadione for Excessive Anticoagulation , 2000, Pharmacotherapy.

[4]  D. Singer,et al.  Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. , 2000, Archives of internal medicine.

[5]  R. Kumar,et al.  Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. , 1999, Archives of internal medicine.

[6]  Robert H. Nee,et al.  Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation. , 1999, The American journal of cardiology.

[7]  M. Crowther,et al.  Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin , 1998, Thrombosis and Haemostasis.

[8]  D. Malone,et al.  Evaluation of excessive anticoagulation in a group model health maintenance organization. , 1998, Archives of internal medicine.

[9]  J. Glover,et al.  Conservative treatment of overanticoagulated patients. , 1995, Chest.

[10]  E. Garelli,et al.  Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[11]  L Goldman,et al.  Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions. , 1989, The American journal of medicine.